Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
European Journal of Cancer (Oxford, England : 1990)|June 23, 2021
Thymic carcinoma with Lynch syndrome or microsatellite instability, a rare entity responsive to immunotherapyM Repetto, F Conforti, S Pirola, et al.
Lung Cancer (Amsterdam, Netherlands)|February 13, 2001
Cisplatin and vinorelbine as second-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) resistant to taxol plus gemcitabineT De Pas, F de Braud, M Mandalà, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2002
Phase I and pharmacological studies of the cryptophycin analogue LY355703 administered on a single intermittent or weekly scheduleC Sessa, K Weigang-Köhler, O Pagani, et al.
Ecancermedicalscience|January 26, 2012
Gemcitabine-induced progressive and sustained tumour response in a patient with multi-drug resistant uterine leiomyosarcomaT De Pas, G Spitaleri, P D Vigna, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 10, 1998
Induction chemotherapy followed by simultaneous hyperfractionated radiochemotherapy in advanced head and neck cancer. A pilot studyB Jereczek-Fossa, F De Braud, M Gasparetto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?T De Pas, F De Braud, L Orlando, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2002
Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomasT De Pas, G Curigliano, G Masci, et al.
Psycho-Oncology|October 15, 2013
The choice of whether to participate in a phase I clinical trial: increasing the awareness of patients with cancer. An exploratory studyC Catania, D Radice, G Spitaleri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Phase II, open-label study of PTK787/ZK222584 for the treatment of metastatic gastrointestinal stromal tumors resistant to imatinib mesylateH Joensuu, F De Braud, P Coco, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimenM Colleoni, G Martinelli, F Beretta, et al.
Pageof 4